Pharma-Bio Serv, Inc.
PBSV- Exchange
- OTC
- Industry
- Services-Management Consulting Services
- SEC CIK
- 0001304161
No open-market purchases or sales by Pharma-Bio Serv, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pharma-Bio Serv, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pharma-Bio Serv, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Spindel Howard | Director | 0Indirect | Jul 22, 2026 | 2 |
| Perlysky Dov | Director | 54,203 | Jan 14, 2026 | 1 |
| Michel Kirk Wheeler | Chairman | 43,602 | Jan 14, 2026 | 1 |
| Wiesen Irving L | Director | 54,250 | Jan 14, 2026 | 1 |
| Lasanta Pedro J | Chief Financial Officer | 119,188 | Dec 28, 2023 | 0 |
| Sanchez Altura Victor | President and CEO | 11,382 | Mar 8, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.